Instrotec rescue plan approved, saving jobs of 480 workers
Judge Reynolds complimented the pragmatic attitude taken by the Revenue Commissioners in deciding to accept the deferment of significant payments due to them in order to save so many jobs.
Advertisement
The court was told that Revenue was not objecting to the scheme of rescue arrangement proposed by Mr Walsh, of JW Accountants, who had been appointed as Examiner to the company. Counsel for Revenue said the jobs included apprentices and those employed in external agency contracts.
Judge Reynolds said the court considered the Examiner's scheme of arrangement fair and equitable to all parties involved and would protect jobs going forward. The judge said Revenue's attitude was very helpful in ensuring survival of the company.
The court heard that Instrotec was a specialist electrical and instrumentation contractor which works on complex projects such as data centres, semiconductor and pharmaceutical facilities, as well as oil and gas plants in Ireland and Europe.
It has 172 apprentices on its books, making it one of the largest trainers of skilled workers in the country. The High Court had been told earlier that the company had a reasonable prospect of survival based on an independent accountant's report prior to the appointment of Mr Walsh as Examiner.
Advertisement
Instrotec, which was founded in 2000 by Donal and Donna Johnston, faced an 'exceptionally challenging' period in the first quarter of this year as three large projects all became loss-making.
At the time, Donal, a time-served electrician with extensive instrumentation and control experience, had identified an opportunity in the market for a specialist contractor in the field of electrical instrumentation and instrument pipefitting.
By coupling this specialist expertise with the provision of traditional industrial electrical systems, Instrotec quickly established a reputation in the growing pharmaceutical and microprocessor manufacturing sectors as the foremost contractor in the provision of instrumentation and control systems.
In recent years, Instrotec had expanded on its existing electrical portfolio to establish a proven track record in the installation of various LV and MV electrical systems across a broad range of sectors and to the highest of industry standards.
Through strengthening this branch of the company, Instrotec had become uniquely positioned to provide an all-encompassing service across instrumentation and control, building management and industrial electrical systems.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
CureVac settles mRNA patent dispute litigation with Pfizer and BioNTech
Aug 7 (Reuters) - German drugmaker CureVac ( opens new tab and GSK (GSK.L), opens new tab reached an agreement with BioNTech ( opens new tab and Pfizer (PFE.N), opens new tab on Thursday to resolve a years-long patent dispute related to mRNA-based COVID-19 vaccines, CureVac said. As part of the settlement, CureVac and GSK will receive a combined payment of $740 million and single-digit royalties on sales of COVID-19 vaccines in the U.S. going forward. CureVac will also grant BioNTech and Pfizer a non-exclusive license to manufacture, use, import and sell mRNA-based COVID-19 and influenza products in the U.S. The settlement comes after BioNTech agreed to acquire its domestic peer CureVac in a $1.25 billion all-stock deal in June. Three years ago, CureVac had filed a patent lawsuit against BioNTech over its use of mRNA technology, seeking fair compensation from the company and two of its subsidiaries for infringement of its intellectual property rights. CureVac had said that its claim to intellectual property rights was based on more than two decades of work on mRNA technology, some of which was used by BioNTech and Pfizer for the development and sale of their Comirnaty coronavirus vaccine. CureVac's efforts to develop an mRNA-based COVID-19 vaccine did not come to fruition during the pandemic, whereas BioNTech and its partner Pfizer chalked up more than $40 billion in combined vaccine sales in 2021 and 2022.
Reuters
an hour ago
- Reuters
CureVac settles patent dispute litigation with Pfizer and BioNTech
Aug 7 (Reuters) - CureVac ( opens new tab said on Thursday that the company and GSK (GSK.L), opens new tab have entered an agreement to a resolve patent dispute with Pfizer (PFE.N), opens new tab and BioNTech ( opens new tab related to mRNA-based COVID-19 vaccines. As part of the settlement, CureVac and GSK will receive a combined payment of $740 million and single-digit royalties on sales of COVID-19 vaccines in the U.S. going forward. CureVac will also grant BioNTech and Pfizer a non-exclusive license to manufacture, use, import and sell mRNA-based COVID-19 and influenza products in the U.S.
The Independent
3 hours ago
- The Independent
‘I've been surviving on handouts': Chaos as 120,000 UK drivers left stranded by ‘do not drive' cars
Hundreds of thousands of UK drivers have been left stranded without transport as a nationwide recall of several popular car models continues to cause chaos. Around 120,000 vehicle owners have been forced off the roads after car manufacturer Stellantis issued a 'do not drive order' for many of its Citroen and DS models on 20 June. The company says it is recalling the affected vehicles for repair in stages. However, the unprecedented scale of the action has left some garages and dealerships admitting that their repair backlog now extends well into next year. In the mean time, owners of the affected models are unable to drive their vehicles – many without alternative modes of transport. The stop-drive order means they also cannot sell their cars, while ignoring it can lead to legal issues such as a fine, driving ban, or points on licence. Stellantis has now been urged by Which? to take urgent action to fix the faults or offer motorists appropriate compensation. The consumer rights group says too many people have been left stranded without any means of transport, causing major disruption to their lives. One customer, Petra*, describes how she has tried many times to get help from Citroen, an is now nearly £900 out of pocket already due to having to hire a car. Her partner has terminal cancer, so she relies on the vehicle to get him to hospital for essential treatments. 'That's my month's money gone,' she told Which?, 'I have to wait for my next benefit payment now, and have been surviving on many handouts from my family for food.' Stellantis has also confirmed that no compensation is being offered to affected drivers, and that courtesy cars can be requested with priority given to customers with 'the most urgent need.' Under consumer laws, any refund or reimbursement for faulty goods must be sought independently from the retailer where the car was purchased, not the manufacturer. This process is independent of the manufacturer, and if unsuccessful the only recourse to take the complaint to court. Eva, a software engineer from Cardiff, had planned to drive to the Netherlands for a camping trip in mid-August, having booked non-refundable ferry and Eurotunnel shuttle bookings. Her DS3 car no longer being drivable meant Eva was forced to consider alternative options, or risk losing £1,000. She was then given a repair date that clashed with a major surgery she was having in London. Faced with missing her surgery and holiday, Eva decided to buy a new car which set her back £10,000. 'This has been a gigantic headache and Stellantis has been resoundingly unhelpful throughout," she said. All the affected car models are equipped with airbags manufactured by Takata, an automative parts company that went bankrupt in 2017. Its airbags inflators are being recalled globally due to chemicals they contain which can deteriorate over time, meaning the airbag can deploy improperly and cause injury. Vicki is a new mother who has a premature baby that requires frequent visits the hospital. After he was born, she drove the child home before learning that the recall was in place. She has been told the soonest her car can be fixed is October. 'I'm a little lost as to what we can do considering we need a car for trips to the hospital,' she said. Which? has urged Stellantis to confirm formal compensation scheme, improve its helpline performance, and provide clearer instructions to its network of garages. Sue Davies, Which? Head of Consumer Protection Policy, said: 'From people left stranded with no means of transport, to those paying out a fortune to hire cars and taxis, the emotional and financial burden of this recall has fallen squarely on those least able to absorb it. 'Stellantis must urgently confirm it will pay compensation for alternative transport as well as offer practical solutions such as offering at-home repairs or towing affected cars to garages. If not, many people will see no alternative but to continue driving cars that are potentially very dangerous. 'The government needs to step in and hold them to account to ensure UK consumers have much greater clarity of what they need to do and what they are entitled to - and are never left in this position again.' A Stellantis spokesperson said: 'The Company's focus remains on completing the replacement of airbags in affected vehicles as swiftly as possible. Our Citroën network is fully engaged in maximising the number of cars that can be completed every day and, to increase our repair capacity even further and minimise as much as possible the impact on customers, our Peugeot network is now authorised to replace airbags on these cars in addition to at home options. 'For each and every customer, we discuss options to support mobility, recognising that every driver has specific requirements. These options include replacement airbags at a dealership or at home, courtesy car, support for other mobility options and recovery. We give priority to those with the most urgent needs.' A DVSA spokesperson said: 'DVSA is supporting Citroën's decision to issue an immediate 'stop drive' recall of (certain models of) the C3 and DS3 and will assist them where needed. 'We are working with Citroën to make sure that everyone with these vehicles knows that they can't use this model of car until the necessary repair work has been carried out. 'To check if your vehicle is affected, car owners can use the checker on Citroën's website.'
